Current Report Filing (8-k)
June 19 2018 - 4:07PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): June 14, 2018
BIOSOLAR,
INC.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
|
000-54819
|
|
20-4754291
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
27936
Lost Canyon Road, Suite 202, Santa Clarita, CA 91387
(Address
of principal executive offices and Zip Code)
Registrant's
telephone number, including area code:
(661) 251-0001
Copies
to:
Gregory
Sichenzia, Esq.
Marcelle
S. Balcombe, Esq.
Sichenzia
Ross Ference Kesner LLP
1185
Avenue of the Americas, 37th Floor
New
York, New York 10036
Phone:
(212) 930-9700
Fax:
(212) 930-9725
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act
of 1933 (§230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.01 Entry into a Material Definitive Agreement.
On June 14, 2018 (the “Effective Date”),
BioSolar, Inc. (the “Company”) entered into an agreement (the “Agreement”) with Silicio Ferrosolar, SLu,
a Spanish limited liability company (“Silicio”), pursuant to which the parties will coordinate a joint development
program of lithium ion battery technology. Specifically, the parties will engage in an on-going collaborative effort to assess,
develop, and/or market silicon anode materials for high power, high energy lithium ion batteries. The Company and Silicio shall
split costs pursuant to the terms of the Agreement, as and when incurred.
The
project commenced on the Effective Date and, unless earlier terminated in accordance with the Agreement, will continue until the
fourth (4
th
) anniversary of the Effective Date. Either Party may terminate the Agreement with or without cause upon
thirty (30) days written notice to the other party.
The
foregoing summary of the terms of the Agreement are subject to, and qualified in its entirety by, such document attached hereto
as Exhibit 10.1 and incorporated herein by reference.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
BIOSOLAR, INC.
|
|
|
|
|
Date: June 19, 2018
|
/s/ David Lee
|
|
|
David Lee
|
|
|
Chief Executive Officer
|
2